Uploaded January 2026 | Updated September 2026, 2 weeks ago
I’m pleased to announce that Professor Robert Lustig will be speaking at Emery Pharma’s Speaker Series on Friday, February 13th at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time.
The title of his presentation is:
“The Role of Oxygen and Reactive Oxygen Species (ROS) in Dementia.”
This will be a fascinating and timely discussion, and for the first time, we are opening this event to the public. We look forward to welcoming as many participants as possible to our live Zoom session.
The Zoom link will be posted in the comments and in the description below.
Professor Lustig is widely known for his work on metabolic health and for raising awareness around:
• The modern food industry
• Diet and exercise
• Good calories vs. bad calories
• Why not all calories are the same
• Ultra-processed foods
• The role of fructose and fatty liver disease
These themes—and more—are sure to come up during the discussion.
We hope you’ll join us and help spread the word.
Looking forward to seeing you there.
Zoom link is here:
Copy paste it into your browser:
Emery Pharma is inviting you to a scheduled Zoom meeting.
Join Zoom Meeting:
us02web.zoom.us/j/85383216455?pwd=MEUyM0vBPS5wwokoXJOAmnW7hMSOlR.1
Meeting ID: 853 8321 6455
Passcode: 948855
About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
I’m pleased to announce that Professor Robert Lustig will be speaking at Emery Pharma’s Speaker Series on Friday, February 13th at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time.
The title of his presentation is:
“The Role of Oxygen and Reactive Oxygen Species (ROS) in Dementia.”
This will be a fascinating and timely discussion, and for the first time, we are opening this event to the public. We look forward to welcoming as many participants as possible to our live Zoom session.
The Zoom link will be posted in the comments and in the description below.
Professor Lustig is widely known for his work on metabolic health and for raising awareness around:
• The modern food industry
• Diet and exercise
• Good calories vs. bad calories
• Why not all calories are the same
• Ultra-processed foods
• The role of fructose and fatty liver disease
These themes—and more—are sure to come up during the discussion.
We hope you’ll join us and help spread the word.
Looking forward to seeing you there.
Zoom link is here:
Copy paste it into your browser:
Emery Pharma is inviting you to a scheduled Zoom meeting.
Join Zoom Meeting:
us02web.zoom.us/j/85383216455?pwd=MEUyM0vBPS5wwokoXJOAmnW7hMSOlR.1
Meeting ID: 853 8321 6455
Passcode: 948855
About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
